Published in Anal Biochem on June 01, 1968
Distribution of isoprenoid quinone structural types in bacteria and their taxonomic implication. Microbiol Rev (1981) 6.91
Biosynthesis of ubiquinone in Escherichia coli K-12: location of genes affecting the metabolism of 3-octaprenyl-4-hydroxybenzoic acid and 2-octaprenylphenol. J Bacteriol (1969) 3.06
Characterization and genetic analysis of mutant strains of Escherichia coli K-12 accumulating the biquinone precursors 2-octaprenyl-6-methoxy-1,4-benzoquinone and 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinone. J Bacteriol (1971) 1.96
The biosynthesis of terpenoid quinones. Biochem J (1969) 0.75
Crystalline Vitamin B12. Science (1948) 8.37
Comparative Data on Vitamin B12 From Liver and From a New Source, Streptomyces griseus. Science (1948) 4.81
STREPTOMYCES ANTIBIOTICS. III. DEGRADATION OF STREPTOMYCIN TO STREPTOBIOSAMINE DERIVATIVES. Science (1945) 3.59
Growth-rate dependent regulation of mRNA stability in Escherichia coli. Nature (1984) 3.06
The stability of E. coli gene transcripts is dependent on determinants localized to specific mRNA segments. Cell (1986) 2.79
Experimental immunohistochemical studies on the localization and distribution of substance P in cat primary sensory neurons. Brain Res (1975) 2.72
A substance P antagonist inhibits vagally induced increase in vascular permeability and bronchial smooth muscle contraction in the guinea pig. Proc Natl Acad Sci U S A (1983) 2.64
Left ventricular systolic dysfunction in 75-year-old men and women; a population-based study. Eur Heart J (2001) 2.46
A novel fusion gene, SYT-SSX4, in synovial sarcoma. J Natl Cancer Inst (1999) 2.36
Substance p: localization in the central nervous system and in some primary sensory neurons. Science (1975) 2.33
Effect of premature termination of translation on mRNA stability depends on the site of ribosome release. Proc Natl Acad Sci U S A (1987) 2.24
Characterization of a gastrin releasing peptide from porcine non-antral gastric tissue. Biochem Biophys Res Commun (1979) 2.16
Worldwide patterns of infertility: is Africa different? Lancet (1985) 2.15
Immunohistochemical analysis of peptide pathways possibly related to pain and analgesia: enkephalin and substance P. Proc Natl Acad Sci U S A (1977) 2.11
Ingestion and survival of Y. pseudotuberculosis in HeLa cells. Can J Microbiol (1975) 2.07
Prolactin and thyrotropin release in man by synthetic pyroglutamyl-histidyl-prolinamide. Biochem Biophys Res Commun (1971) 2.07
Distribution of substance P-like immunoreactivity in the central nervous system of the rat--I. Cell bodies and nerve terminals. Neuroscience (1978) 1.99
STREPTOMYCES ANTIBIOTICS. I. CRYSTALLINE SALTS OF STREPTOMYCIN AND STREPTOTHRICIN. Science (1945) 1.98
Immunohistochemical evidence for separate populations of somatostatin-containing and substance P-containing primary afferent neurons in the rat. Neuroscience (1976) 1.92
A specific substance P antagonist blocks smooth muscle contractions induced by non-cholinergic, non-adrenergic nerve stimulation. Nature (1981) 1.76
Localization of substance P-like immunoreactivity in mouse gut. Histochemistry (1975) 1.71
Immunohistochemical evidence of substance P-like immunoreactivity in some 5-hydroxytryptamine-containing neurons in the rat central nervous system. Neuroscience (1978) 1.67
Myocardial infarction and prevalence of diabetes mellitus. Is increased casual blood glucose at admission a reliable criterion for the diagnosis of diabetes? Eur Heart J (2001) 1.66
The identity of chemical and hormonal properties of the thyrotropin releasing hormone and pyroglutamyl-histidyl-proline amide. Biochem Biophys Res Commun (1969) 1.62
On the occurrence of substance P-containing fibers in sympathetic ganglia: immunohistochemical evidence. Brain Res (1977) 1.55
Vitamin B12, A Cobalt Complex. Science (1948) 1.53
Calculation of the electromyographic jitter. J Neurol Neurosurg Psychiatry (1974) 1.49
Chemical design of antagonists of substance P. Acta Physiol Scand (1981) 1.49
Activity and specificity of synthetic thyrotropin-releasing hormone in man. Biochem Biophys Res Commun (1970) 1.47
2-multiprenylphenols and 2-decaprenyl-6-methoxyphenol, biosynthetic precursors of ubiquinones. J Am Chem Soc (1966) 1.43
Peptide neurons in the vagus, splanchnic and sciatic nerves. Acta Physiol Scand (1978) 1.42
Mass spectra of ubiquinones and ubiquinols. J Am Chem Soc (1967) 1.42
Autoimmune thyroid dysfunction in the postpartum period. J Clin Endocrinol Metab (1984) 1.41
The pharmacological profile of a substance P (SP) antagonist. Evidence for the existence of subpopulations of SP receptors. Acta Physiol Scand (1983) 1.40
Cigarette smoke-induced airway oedema due to activation of capsaicin-sensitive vagal afferents and substance P release. Neuroscience (1983) 1.40
Biological evaluation of substance P antagonists. Br J Pharmacol (1984) 1.39
Evaluation of quality of life after laparoscopic surgery: evidence-based guidelines of the European Association for Endoscopic Surgery. Surg Endosc (2004) 1.36
New multiprenylquinones in the biosynthesis of ubiquinone. Biochem Biophys Res Commun (1967) 1.35
Collection of standardized information on infant feeding in the context of mother-to-child transmission of HIV. Stat Med (2001) 1.34
Substance P: release on trigeminal nerve stimulation, effects in the eye. Acta Physiol Scand (1979) 1.33
Piericidin A: a new inhibitor of mitochondrial electron transport. Biochem Biophys Res Commun (1966) 1.32
Peptidergic (substance P) nerves in the genito-urinary tract. Neuroscience (1978) 1.31
Release of substance P-like immunoreactivity from the dental pulp. Acta Physiol Scand (1977) 1.30
Plasma gastrin and gastric acid responses to sham feeding and feeding in dogs. Gastroenterology (1972) 1.29
Recombinant human stem cell factor stimulates differentiation of mast cells from dispersed human fetal liver cells. Blood (1992) 1.28
Expression and function of chemokine receptors in human multiple myeloma. Leukemia (2003) 1.26
A synthetic peptide that is a bombesin receptor antagonist. Nature (1984) 1.24
Effect of topical application of coenzyme Q10 on adult periodontitis. Mol Aspects Med (1994) 1.21
Lovastatin decreases coenzyme Q levels in rats. Proc Natl Acad Sci U S A (1990) 1.20
A substance P antagonist, [D-Pro2, D-Trp7,9]SP, inhibits inflammatory responses in the rabbit eye. Science (1981) 1.20
Essential role of the prosurvival bcl-2 homologue A1 in mast cell survival after allergic activation. J Exp Med (2001) 1.20
Deficiency of coenzyme Q 10 in human heart disease. II. Int J Vitam Nutr Res (1972) 1.19
Substance P-, VIP-, and enkephalin-like immunoreactivity in the human vagus nerve. Gastroenterology (1979) 1.19
Expression of insulin-like growth factor-1 receptor in synovial sarcoma: association with an aggressive phenotype. Cancer Res (1999) 1.18
VIP-, enkephalin-, substance P- and somatostatin-like immunoreactivity in neurons intrinsic to the intestine: immunohistochemical evidence from organotypic tissue cultures. Brain Res (1978) 1.18
Water intoxication associated with non-steroidal anti-inflammatory drug therapy. Acta Med Scand (1987) 1.18
Low-molecular-mass surfactant protein type 1. The primary structure of a hydrophobic 8-kDa polypeptide with eight half-cystine residues. Eur J Biochem (1988) 1.17
Colon cleansing regimens. A clinical study in 1200 patients. Gastrointest Radiol (1982) 1.17
Inhibition of antidromic and substance P-induced vasodilatation by a substance P antagonist. Acta Physiol Scand (1981) 1.16
Proapoptotic Bcl-2 family member Bim is involved in the control of mast cell survival and is induced together with Bcl-XL upon IgE-receptor activation. Cell Death Differ (2005) 1.15
Discovery of inhibitory activity of tenuazonic acid for growth of human adenocarcinoma-1. Biochem Biophys Res Commun (1964) 1.15
Human mast cell migration in response to members of the transforming growth factor-beta family. J Leukoc Biol (2000) 1.14
Presence of substance P-like immunoreactivity in plasma from man and dog. Acta Physiol Scand (1975) 1.13
The precision of the conjunctival provocation test. Allergy (1984) 1.13
Changed skin blood perfusion in the fingertip following acupuncture needle introduction as evaluated by laser Doppler perfusion imaging. Lasers Med Sci (2002) 1.13
Studies on subclinical hypothyroidism with special reference to the serum lipid pattern. Acta Med Scand (1976) 1.13
Deficiency of coenzyme Q 10 in human heart disease. I. Int J Vitam Nutr Res (1972) 1.12
Deficiency of coenzyme Q 10 in gingival tissue from patients with periodontal disease. Proc Natl Acad Sci U S A (1971) 1.12
Testicular volume, semen profile and serum hormone levels in fertile Thai males. Int J Androl (1986) 1.12
Evidence for a deficiency of coenzyme Q10 in human heart disease. Int Z Vitaminforsch (1970) 1.11
Inhibition of gastric and intestinal motor activity in dogs by (Gln4) neurotensin. Acta Physiol Scand (1977) 1.10
Assessing the acceptability, service delivery requirements, and use-effectiveness of the diaphragm in Colombia, Philippines, and Turkey. Contraception (2001) 1.10
Prostitution, condom use, and invasive squamous cell cervical cancer in Thailand. Am J Epidemiol (1996) 1.10
Clinical results of a cross-over treatment with pyridoxine and placebo of the carpal tunnel syndrome. Am J Clin Nutr (1979) 1.10
Third-generation oral contraceptives and venous thrombosis. Lancet (1997) 1.09
Reliability of data from proxy respondents in an international case-control study of cardiovascular disease and oral contraceptives. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. J Epidemiol Community Health (1996) 1.08
[Are mortality figures from the National Board of Health and Welfare acceptable as a quality indicator in myocardial infarction?]. Lakartidningen (1997) 1.08
Time-course of development and reversal of gastric endocrine cell hyperplasia after inhibition of acid secretion. Studies with omeprazole and ranitidine in intact and antrectomized rats. Gastroenterology (1988) 1.08
Response of vitamin B-6 deficiency and the carpal tunnel syndrome to pyridoxine. Proc Natl Acad Sci U S A (1982) 1.08
Deficiency of coenzyme Q in gingiva of patients with periodontal disease. Int J Vitam Nutr Res (1973) 1.07
Biochemical rationale and myocardial tissue data on the effective therapy of cardiomyopathy with coenzyme Q10. Proc Natl Acad Sci U S A (1985) 1.07
Immunohistochemical studies on the effect of capsaicin on spinal and medullary peptide and monoamine neurons using antisera to substance P, gastrin/CCK, somatostatin, VIP, enkephalin, neurotensin and 5-hydroxytryptamine. J Neurocytol (1981) 1.07
Peptide neurons in peripheral tissues including the urinary tract: immunohistochemical studies. Acta Pharmacol Toxicol (Copenh) (1978) 1.06
Distinct and regulated expression of Notch receptors in hematopoietic lineages and during myeloid differentiation. Eur J Immunol (2001) 1.06
SYNTHETIC VITAMIN B6. Science (1939) 1.06
Synthetic thyrotropin-releasing hormone. Activity in men and women, specificity of action, inhibition by triiodothyronine, and activity orally. J Med Chem (1971) 1.05
The differential stability of the Escherichia coli ompA and bla mRNA at various growth rates is not correlated to the efficiency of translation. Gene (1988) 1.05
A substance P antagonist inhibits a slow reflex response in the spinal cord of the newborn rat. Acta Physiol Scand (1982) 1.05
A gastrin releasing peptide from the porcine nonantral gastric tissue. Gut (1978) 1.05
Effect of surgical splitting on vascular reactions in the superficial flexor tendon of the horse. J Am Vet Med Assoc (1974) 1.04
The chemokine receptor CXCR4 is expressed within the mast cell lineage and its ligand stromal cell-derived factor-1alpha acts as a mast cell chemotaxin. Eur J Immunol (2000) 1.04
The analysis of menstrual bleeding patterns: a review. Contraception (1988) 1.04
The effect of food ingestion on circulating neurotensin-like immunoreactivity (NTLI) in the human. Acta Physiol Scand (1978) 1.04
Inhibition of mitochondrial electron transport by piericidin A and related compounds. Biochemistry (1968) 1.04
Studies on replacement and suppressive dosages of 1-thyroxine. Acta Med Scand (1977) 1.04
Rhodanine: a selective inhibitor of the multiplication of echovirus 12. Science (1970) 1.03
Peptides in the cat carotid body (glomus caroticum): VIP-, enkephalin-, and substance P-like immunoreactivity. Acta Physiol Scand (1979) 1.03
Laser-Doppler perfusion imaging of microvascular blood flow in rabbit tenuissimus muscle. Am J Physiol (1995) 1.03